Blog
A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.
A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.
Liver Life Challenge leaders set the tone for training, fundraising, and race day camaraderie. Meet the standout individuals of 2025 and discover what fuels them to push limits and champion the fight against liver disease.
Dr. Roberts’s research lights the way to earlier detection and better outcomes for liver cancer patients, especially in the Black Community. ALF turns that light into action on the ground. See how we're working together to address barrier and advance health equity in at-risk communities.
A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.
A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.
Leading medical experts and patient advocates came together last week for a Congressional Briefing hosted by American Liver Foundation (ALF) on Liver Cancer: Prevalence, Risk Factors, and Strategies for Prevention and Treatment.
A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.
See how two celebrities brought their personal struggles with liver disease into the national spotlight last year to raise awareness around this silent killer.
American Liver Foundation (ALF) proudly announces its 50th anniversary, marking five decades of unwavering commitment to advancing liver health, empowering liver patients and their families, providing groundbreaking public health initiatives and programs, and funding close to $30 million in critical research that supports and educates the 100 million Americans living with some form of liver disease.
A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.
ALF is deeply disappointed that the Advisory Committee on Immunization Practices (ACIP) voted this morning to end the highly effective universal hepatitis B (hep B) birth dose recommendation for infants.